Dr Katarina Ilic (Serbia / USA)
MD, MSc, PhD, MPH, FISoP
Head of Drug Safety and Risk Management | Professor of Pharmacology

Dr Katarina Ilic is an accomplished pharmacovigilance and drug safety expert with more than two decades of experience spanning academia, regulatory affairs, consultancy, and the pharmaceutical industry. She has held senior leadership roles including Executive Head of Drug Safety and Risk Management at Celldex Therapeutics and Raptor Pharmaceuticals, and Senior Director of Pharmacovigilance and Risk Management at Exelixis. Her academic career includes serving as Professor and Head of Pharmacology at Trinity School of Medicine and Associate Professor at the University of Belgrade.

A Fellow of ISoP, Dr Ilic has been deeply involved in the Society’s activities as Scientific Board Member, Communications Lead, founder and coordinator of the South-Eastern European (SEE) Chapter, and Chair or speaker at numerous ISoP meetings. She is also Chair of the Global Health Community of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) and an active contributor to global health initiatives.

Dr Ilic’s vision for pharmacovigilance emphasizes global harmonization, patient-centred innovation, and proactive safety strategies that bridge science, education, and policy. She is committed to fostering collaboration across disciplines and regions to strengthen pharmacovigilance as a dynamic and inclusive field.